FIVE YEARS OF FOLLOW-UP FROM THE PHASE 3 RESONATE-2 STUDY AND NURSING EXPERIENCE WITH PATIENTS RECEIVING FIRST-LINE IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA Greenberg, E. M., Settlemire, M., Lal, I., Amaya-Chanaga, C., Coutre, S., Burger, J. A. ONCOLOGY NURSING SOC. 2020

View details for Web of Science ID 000569150400300